alprazolam has been researched along with Kidney Failure, Chronic in 5 studies
Alprazolam: A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)
alprazolam : A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " There was also a tendency for a later Tmax and a longer elimination half-life in CAPD patients than in normal subjects or HD patients." | 2.67 | Alprazolam in end-stage renal disease: I. Pharmacokinetics. ( Kroboth, PD; Piraino, B; Schmith, VD; Smith, RB, 1991) |
| "6." | 1.28 | Platelet-activating factor mediates glycerol-induced acute renal failure in rats. ( Bernabeu, F; Braquet, P; Gómez-Garre, D; López-Farré, A; López-Novoa, JM; Perez-Rodrigo, P; Ramón y Cajal, S, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Güner Can, M | 1 |
| Ilgaz Koçyiğit, Ö | 1 |
| Aksu, U | 1 |
| Özer, A | 1 |
| Toraman, F | 1 |
| Schmith, VD | 2 |
| Piraino, B | 2 |
| Smith, RB | 3 |
| Kroboth, PD | 2 |
| López-Farré, A | 1 |
| Gómez-Garre, D | 1 |
| Bernabeu, F | 1 |
| Ramón y Cajal, S | 1 |
| Perez-Rodrigo, P | 1 |
| Braquet, P | 1 |
| López-Novoa, JM | 1 |
| Ochs, HR | 1 |
| Greenblatt, DJ | 1 |
| Labedzki, L | 1 |
3 trials available for alprazolam and Kidney Failure, Chronic
| Article | Year |
|---|---|
Effect of Alprazolam on Redox Status in Renal Transplantation Donors and Recipients.
Topics: Adult; Aged; Alprazolam; Female; GABA Modulators; Humans; Kidney Failure, Chronic; Kidney Transplant | 2017 |
Alprazolam in end-stage renal disease. II. Pharmacodynamics.
Topics: Adult; Alprazolam; Double-Blind Method; Female; Humans; Kidney Failure, Chronic; Male; Motor Activit | 1992 |
Alprazolam in end-stage renal disease: I. Pharmacokinetics.
Topics: Adult; Alprazolam; Double-Blind Method; Female; Humans; Kidney Failure, Chronic; Male; Peritoneal Di | 1991 |
2 other studies available for alprazolam and Kidney Failure, Chronic
| Article | Year |
|---|---|
Platelet-activating factor mediates glycerol-induced acute renal failure in rats.
Topics: Acute Kidney Injury; Alprazolam; Animals; Disease Models, Animal; Diterpenes; Ginkgolides; Glomerula | 1990 |
Alprazolam kinetics in patients with renal insufficiency.
Topics: Adolescent; Adult; Aged; Alprazolam; Female; Humans; Kidney Failure, Chronic; Kinetics; Male; Middle | 1986 |